Peptides are one of the hottest topics in orthopedics and sports medicine right now, and one of the most misunderstood. You hear about them at the gym, on podcasts, and all over social media. Some people call them snake oil. Others promote them with more confidence than the science can back up. The truth sits somewhere in between.
This review does not argue for or against peptides. Patients ask about them often, some physicians use them carefully after a thorough talk with the patient, and the science behind them is interesting. Our goal is simple: explain, in plain language, where the research stood in late 2026. For each peptide, we cover what it is, why people are interested, why caution is needed, how it is made and tested, what it is often combined with, and which popular claims are myths.
First, what is a peptide?
A peptide is a short chain of amino acids. Amino acids are the building blocks of protein. Your body makes many peptides on its own and uses them as messengers. They tell cells to grow, repair damage, calm inflammation, or release hormones. A peptide used as a treatment may copy one of these natural messengers, use a piece of a natural protein, or be made entirely in a lab to act on the same pathway.
Peptides are not fringe medicine as a group. Several are well-tested, FDA-approved drugs used every day. Examples include insulin, GLP-1 weight-loss and diabetes drugs such as semaglutide and tirzepatide, and the osteoporosis drugs teriparatide and abaloparatide, which help build bone. So the real question is never "Do peptides work?" The real question is "Has this specific peptide been shown to help this specific problem in people?"
Because peptides are small and act on specific targets, researchers are interested in using them to help tendons, ligaments, muscle, and cartilage heal. But being targeted is not the same as being proven. Something that helps a tendon heal in a rat will not necessarily heal a torn rotator cuff in a person.
Peptides with human evidence in orthopedics
Before we get to the peptides you hear about online, it helps to know that some peptides have already been tested in people, with proper comparison groups, for bone and joint care.
Teriparatide and abaloparatide (bone-building peptides). Both are FDA-approved for osteoporosis in patients with a high risk of breaking a bone. When fracture studies are pooled together, teriparatide seems to improve pain and function after some fractures, but it does not reliably help more fractures heal (Kostenuik et al., Current Osteoporosis Reports, 2023). In spinal fusion surgery, one large analysis found that teriparatide combined with another bone drug, denosumab, led to more successful fusions than a placebo. Teriparatide by itself did not perform much differently from placebo or from bisphosphonates, a common class of bone drugs (Cheng et al., PLoS One, 2020). Using these drugs to speed fracture healing in people who do not have osteoporosis is off-label, meaning it is not an approved use.
Collagen peptides (oral, food-derived). In a well-designed trial comparing collagen with a placebo, people who took specific collagen peptides for 14 weeks while doing strength training grew a thicker Achilles tendon than people who did the training alone. However, tendon stiffness and strength improved about the same in both groups (Jerger et al., Scandinavian Journal of Medicine & Science in Sports, 2022). A 2026 review of six human studies on tendon and ligament injuries found a "cautiously positive signal" for collagen peptides as an add-on to rehab or recovery after surgery. Still, there were few studies, they differed from one another, and the overall evidence was weak (Latini et al., Frontiers in Medicine, 2026).
These examples show that peptides can be tested properly in orthopedic patients. They also set a standard that the newer, more popular peptides have not yet met.
The peptides most discussed online
BPC-157 (Body Protection Compound-157)
BPC-157 is a lab-made peptide, 15 amino acids long, based on a protein found in human stomach juice.
Why people are interested: BPC-157 has more animal research on bone, muscle, and joint healing than any other peptide in this review. In studies, mostly in rats and mice, it has been linked to better healing of tendons, ligaments, muscle, and bone (Tham et al., Journal of the American Academy of Orthopaedic Surgeons, 2026). Scientists think it may work by helping new blood vessels form, boosting certain healing signals, and calming inflammation. Toxicity studies have not found a dose that is lethal, and it has been tested for safety in early trials for inflammatory bowel disease (Mayfield et al., American Journal of Sports Medicine, 2026). There are three small human reports:
- Knee pain:In a look back at past patients, 11 of 12 people who got BPC-157 injected into the knee said their pain improved a lot and stayed better for more than 6 months. Three of 4 patients who got BPC-157 together with thymosin beta-4 also said they improved (Luansritisakul et al., Current Pain and Headache Reports, 2026).
- Interstitial cystitis:Among 12 women with a painful bladder condition, 10 said their symptoms went away completely after a single injection into the bladder wall. No side effects from the treatment were reported (Luansritisakul et al., 2026).
- Safety pilot:Two healthy adults were given BPC-157 through an IV. They had no side effects or abnormal lab results, and the peptide was gone from their blood within 24 hours (Luansritisakul et al., 2026).
Why caution is needed: None of these human reports compared patients to a group that did not get the treatment. The knee study depended on patients remembering how they felt and did not use standard scoring tools, so its results may be skewed (Mendias and Awan, Sports Medicine, 2026). A 2025 review found 36 studies published between 1993 and 2024. Of these, 35 were in animals or the lab, and only 1 was in people (Vasireddi et al., HSS Journal, 2025). No one knows the right dose, how the body processes the drug, or whether it is safe over the long term (Tham et al., 2026). There is also a possible concern in theory. BPC-157 seems to work mainly by growing new blood vessels. High levels of a related growth signal, called VEGF, are linked to worse outcomes in cancer. New blood vessel growth is also linked to worse function in chronic tendinopathy, the most common kind of tendon problem doctors see (Mendias and Awan, 2026).
Status: BPC-157 is not FDA-approved for any use. Since 2022, the World Anti-Doping Agency (WADA) has banned it at all times, in and out of competition, as an unapproved substance (category S0) (McGuire et al., Current Reviews in Musculoskeletal Medicine, 2025).
TB-500 and thymosin beta-4
Thymosin beta-4 is a protein, 43 amino acids long, found throughout the body. After an injury, platelets and immune cells release it to help start the repair process. TB-500 is a lab-made piece of it, just 7 amino acids long. People often treat TB-500 and the full protein as the same thing, but there is no proof that they act the same way in the body or give the same results (Tham et al., 2026).
Why people are interested: The full thymosin beta-4 protein has been tested in people more than most peptides in this review. Early safety trials found it generally safe for short-term use, with side effects similar to a placebo. An eye-drop version looked safe and helpful in small trials for a rare eye surface disease. In a heart attack trial it was safe, though results on heart damage were mixed (Mendias and Awan, 2026). In animals, it helped skin wounds heal faster and helped muscle regrow (Mendias and Awan, 2026).
Why caution is needed: For bones, joints, and muscles, the evidence comes only from lab and rodent studies. Results in the eye, skin, and heart cannot tell us whether it is safe or helpful for tendons or muscle (Tham et al., 2026). In animals with muscle injuries, more new muscle fibers did not lead to more strength (Mendias and Awan, 2026). Research on TB-500 itself has mostly described the molecule. It has not tested whether TB-500 is safe or works (Mendias and Awan, 2026). TB-500 is not FDA-approved and is banned by WADA under S0.
GHK-Cu (glycyl-histidyl-lysine copper)
GHK-Cu is a natural peptide that carries copper. It is found in human blood, saliva, and urine.
Why people are interested: Levels in the blood drop with age, from about 200 ng/mL at age 20 to about 80 ng/mL by age 60. In animal studies across several species, it improved wound healing, collagen production, and blood vessel growth (Pickart et al., BioMed Research International, 2014). It is a common ingredient in skin creams and serums.
Why caution is needed: No human studies have tested it for tendon, ligament, joint, or long-term pain problems. The body clears it within about 30 to 60 minutes (Luansritisakul et al., 2026). Because it helps blood vessels grow, scientists are still studying whether it could play a role in tumor growth. There is also no evidence that it builds muscle (Mayfield et al., 2026).
KPV (lysine-proline-valine)
KPV is a tiny piece of a natural hormone called alpha-melanocyte-stimulating hormone. It is being studied for its ability to calm inflammation, mainly in gut and skin research. Evidence for bone and joint use is early and limited to the lab. We include it here because it was part of the 2026 FDA advisory meeting described below.
Growth-hormone secretagogues: CJC-1295, ipamorelin, and sermorelin
These peptides do not repair tissue directly. Instead, they prompt your body to release more of its own growth hormone. That raises IGF-1, a growth factor that helps maintain tissues.
Why people are interested: In a well-designed, placebo-controlled trial in healthy adults aged 21 to 61, CJC-1295 raised growth hormone 2 to 10 times for at least 6 days, and raised IGF-1 1.5 to 3 times for 9 to 11 days. No serious side effects were reported (Teichman et al., Journal of Clinical Endocrinology and Metabolism, 2006). There is also some support for targeting growth hormone in general. In a small trial, patients who took prescription growth hormone for 6 weeks around ACL surgery gained nearly a third more thigh (quadriceps) strength than those on placebo. But patients in both groups reported similar results in how they felt and functioned (Mendias et al., American Journal of Sports Medicine, 2020).
Why caution is needed: No clinical studies have tested CJC-1295 for orthopedic problems (Mayfield et al., 2026). In a trial that tested rising doses, 94% of people taking CJC-1295 had side effects, compared with 29% on placebo. These included reactions at the injection site, headache, diarrhea, and flushing. A later trial in patients with HIV-related fat changes was stopped after a participant died, although experts disagreed about whether the drug caused the death (Mendias and Awan, 2026). Keeping growth hormone levels high for a long time can also cause insulin resistance (a step toward diabetes) and fluid buildup (Mendias and Awan, 2026).
A related warning comes from MK-677 (ibutamoren). It is a pill, not a peptide, but it also boosts growth hormone and is often sold alongside these peptides. In a trial of 123 older adults recovering from a hip fracture, MK-677 raised IGF-1, but most measures of physical function did not improve. The trial was stopped early because of signs that it could cause heart failure (Adunsky et al., Archives of Gerontology and Geriatrics, 2011). These compounds are banned in sports.
How peptides are made and given in research
Most research peptides are built in a lab by adding amino acids one at a time, a process called solid-phase peptide synthesis. The result is purified and freeze-dried into a powder, which must be mixed with liquid before use. Whether the product is pure, sterile, and actually what the label says depends entirely on who made it. Products sold online have been flagged for problems with all of these: wrong ingredients, low purity, wrong strength, contamination, and differences from one batch to the next (Tham et al., 2026).
In animal studies, peptides are usually injected under the skin, into a muscle, or straight into a joint or injured area. That is because the stomach usually breaks peptides down when they are swallowed. Some are studied as pills, nasal sprays, or creams, but how well they are absorbed varies a lot from one peptide to another. This review does not give doses. Without an FDA-approved label, there is no standard dose to refer to, and a dose used in rats cannot simply be scaled up into a safe dose for people.
Common pairings, and what they actually mean
BPC-157 + TB-500 (the "Wolverine stack"). This is a marketing name, not a medical treatment plan. The idea is that one peptide helps blood vessels grow while the other helps cells move into the injured area. The only human data on this combination come from 4 patients in a knee pain report with no comparison group (Luansritisakul et al., 2026). No one has shown that the pair works better than either peptide alone.
CJC-1295 + ipamorelin. This pairing is meant to create stronger bursts of growth hormone while avoiding the effects of nonstop stimulation. However, keeping growth hormone high for long periods can blunt the body's own growth hormone system over time (Mendias and Awan, 2026). The pairing makes sense on paper, but that is not proof that it improves healing.
GHK-Cu + collagen or wound-care peptides. This pairing is based on skin and collagen science, not on any tested orthopedic treatment plan.
Combining peptides does not make an unproven treatment proven. It also makes safety harder to judge, because if a side effect happens, you cannot tell which product caused it.
What changed in 2026?
Several major reviews came out this year, and they largely agree. A review in the American Journal of Sports Medicine looked at BPC-157, TB-500, CJC-1295, MK-677, ipamorelin, and GHK-Cu. It found that their popularity has gotten ahead of the science. Animal results look promising, but steady, meaningful benefits have not been shown in people. The few human studies also found safety concerns, including heart failure and problems with blood sugar control (Tewari et al., American Journal of Sports Medicine, 2026). A companion review in Sports Medicine came to similar conclusions. It added that the placebo effect, boosted by social media, may explain some of the benefits people report (Mendias and Awan, 2026). In October, a review in the Journal of the American Academy of Orthopaedic Surgeons concluded that peptides cannot yet be recommended for routine use. It encouraged surgeons to ask patients openly about peptide use instead of avoiding the subject (Tham et al., 2026).
There was also regulatory news, and it is easy to misread. In September 2023, the FDA restricted pharmacies from compounding (custom-mixing) these peptides. The concerns included immune reactions, the peptide clumping together, impurities, and difficulty confirming what the product actually contains (Samantaroy et al., JAMA, 2026). On July 23 and 24, 2026, an FDA advisory committee on pharmacy compounding reviewed seven peptides for possible addition to the list of substances pharmacies may compound (the 503A list). FDA staff scientists had recommended against adding any of the seven. The committee still voted in favor of six, including BPC-157, TB-500, and KPV, and voted 7 to 6 against the seventh (Samantaroy et al., 2026).
That vote is only a recommendation. It is not a drug approval and not a final rule, and the FDA had not finished its rulemaking when this review was written. Even if the rule becomes final, these compounding pharmacies (known as 503A pharmacies) do not have to follow federal manufacturing-quality rules (called cGMP), report side effects, or meet labeling requirements (Samantaroy et al., 2026). Easier access through compounding would not mean FDA-checked quality or proven benefit. Until a final rule changes things, peptides sold in the United States as "research use only" are not prescription medicines. That label does not make a product legal or safe for people to use.
The FDA has also warned about risks from injected peptides, including immune reactions tied to clumping and impurities. Individual case reports cannot prove a peptide caused a problem, but they are a reminder that "natural" and "small" do not mean risk-free.
Myths and rumors, in plain terms
Myth: "Peptides are all snake oil." Several peptides are FDA-approved drugs backed by large studies, including bone-building medicines used in orthopedic patients. Each peptide has to be judged on its own evidence.
Myth: "Peptides are FDA-approved for injury recovery." As of late October 2026, no peptide is FDA-approved to help muscles, tendons, or ligaments recover (Mayfield et al., 2026).
Myth: "Research use only means it is safe to use." That label only describes how a chemical is sold. It says nothing about whether it is safe, pure, or legal to inject.
Myth: "Natural means safe." Peptides are often advertised as natural, so some people assume they are safe, even at doses far higher than the body makes on its own (Tewari et al., 2026).
Myth: "Animal studies prove it works in people." Animals heal faster and more completely than people do. Also, most tendon problems in people build up slowly over time from wear and tear, unlike the sudden injuries studied in animals.
Myth: "If athletes use it, it must be allowed." BPC-157 and TB-500 are banned by WADA at all times.
Rumor: "The FDA just approved BPC-157." What happened in July 2026 was an advisory committee recommendation about whether pharmacies may compound it. It was not FDA approval of a drug.
Rumor: "Peptides can replace surgery." No peptide has been shown to reattach a torn tendon, rebuild a torn labrum, or take the place of a surgical repair.
Where does that leave patients?
Peptides are a real area of research, and the science is interesting enough to deserve better human studies. Even experts who are cautious about using them today agree on that (McGuire et al., 2025). For now, here is the honest summary: promising results in the lab and in animals, a few encouraging human reports without comparison groups, no approved orthopedic use, real concerns about the quality and safety of unregulated products, and rules that are still changing.
If you are thinking about using a peptide, or already using one, tell your surgeon. Your care team cannot help you weigh the risks, check for drug interactions, or catch side effects early if they do not know. Recent orthopedic reviews encourage exactly this kind of open, judgment-free conversation, along with making decisions together and keeping an eye out for side effects when peptides are used (Mendias and Awan, 2026; Tham et al., 2026).
If you have already decided to use a peptide: practical safety guidance
Many readers have already made up their minds, and some are already using peptides. This section is not an endorsement. It is here to help you lower the risks you can control. Keep in mind that none of the peptides in this review has a proven human dose, schedule, or treatment length for any orthopedic condition. Experts writing for orthopedic surgeons say the right uses, doses, frequency, and duration are all unknown (Mayfield et al., 2026). So the steps below are practical safety measures, not a tested treatment plan.
Before you start
- Get a clear diagnosis first.Know exactly what you are treating: a partial tear, long-term tendon wear (tendinopathy), arthritis, or something else. You cannot tell whether a peptide is helping if the problem has not been clearly identified. A peptide should also never delay a treatment that is known to work, such as a structured rehab program or a needed surgical repair.
- Review your health history honestly.The possible concerns about BPC-157, GHK-Cu, and growth hormone boosters involve blood vessel growth and signals linked to cancer (Tewari et al., 2026; Mendias and Awan, 2026). That makes active cancer, or a recent history of cancer, an important reason for caution. People with diabetes, prediabetes, or heart failure should be especially careful with growth hormone boosters and MK-677, because these have been shown to affect insulin, blood sugar, fluid buildup, and heart failure (Tewari et al., 2026). There is no safety information for use during pregnancy or breastfeeding.
- Get baseline labs if you plan to use a growth hormone secretagogue.There is no lab-testing schedule made specifically for peptides. For people on prescription growth hormone, hormone specialists check IGF-1, fasting blood sugar, hemoglobin A1c (a measure of average blood sugar), and cholesterol, along with weight and waist size (Yuen et al., American Association of Clinical Endocrinology, 2019; Molitch et al., Endocrine Society, 2011). Getting these tests before you start gives you something to compare against later. Using these same tests for growth hormone boosters makes sense, but it has not been proven.
- Check whether you are drug tested.BPC-157, TB-500, and the growth hormone boosters are banned by WADA. BPC-157 can reportedly be detected for 48 to 72 hours after use (Tewari et al., 2026). If you are a tested athlete, do not assume "a short course" is safe.
- Start one product at a time.If you take several at once and have a side effect, you cannot tell which product caused it. The same goes for any benefit.
- Decide in advance how you will measure success.Pick something concrete, such as a pain score, a specific activity, a strength test, or getting back to your sport, and write it down before you begin. The placebo effect and simple expectation are strong with these products (Mendias and Awan, 2026). Setting a goal ahead of time is the most honest way to judge whether a peptide is really helping.
Where the product comes from matters as much as which peptide it is
The biggest risk you can control is product quality. Gray-market peptides are made without the quality controls that regulated drugs must follow. Published testing shows wide differences in purity, ingredients, and contamination with chemicals and metals (Mendias and Awan, 2026). In one study of fake peptide drugs bought from illegal online pharmacies, some peptides were only 5% to 75% pure. Several samples contained arsenic at up to 10 times the safe limit for injectable drugs, and one contained lead (Janvier et al., Talanta, 2018). In 2026, independent testing of an illegal peptide sold online found that it was the right compound, but the actual amount ranged from about half to almost double what the label said (Piatkowski et al., JAMA, 2026). In the related supplement market, only 52% of products contained the ingredients on the label (Tewari et al., 2026).
Compounding pharmacies are not the same as "research use only" websites, but they are also not the same as FDA-approved drug makers. Traditional 503A pharmacies must follow United States Pharmacopeia standards, but they do not have to follow federal manufacturing-quality rules (cGMP). As of this writing, BPC-157, CJC-1295, ipamorelin, and TB-500 are still on the FDA list that effectively prevents pharmacies from compounding them, while a final rule is pending (Mendias and Awan, 2026; Samantaroy et al., 2026).
Safer injection basics
If a product is injected, infection is a real risk, and one you can prevent. The standard safety advice for anyone who gives themselves injections applies here (Shah et al., JAMA, 2025):
- Use a new, sterile needle and syringe for every injection, and never share or reuse supplies.
- Clean the skin with an alcohol swabfor at least 30 seconds before injecting.
- Never lick a needle or touch the tip.
- Throw used needles away in a proper sharps container.
- Make sure your tetanus and hepatitis B vaccines are up to date. Both are recommended for people who inject (Yucel et al., Journal of the American College of Cardiology, 2022).
Injections into a joint, a tendon, or near a surgical repair carry extra risks. Do not do these yourself.
What to watch for, and when to seek care
Stop using the product and get medical care right away if you notice any of the following:
- Signs of infection:redness, warmth, or swelling that spreads beyond the injection site; pus; fever or chills; or a joint that becomes hot, swollen, and painful.
- Signs of an allergic or immune reaction:hives, swelling of the lips, face, or throat, wheezing, or shortness of breath. Call 911 if your throat swells or you have trouble breathing. The FDA has specifically warned about immune reactions with compounded peptides (Samantaroy et al., 2026).
- Growth hormone effects(CJC-1295, ipamorelin, sermorelin, MK-677): swollen hands or feet, achy joints, numbness or tingling in the hands, headaches, more thirst or urination than usual, unexplained weight gain, leg swelling, or shortness of breath when lying flat. These match known side effects of growth hormone treatment and the heart failure warning seen with MK-677 (Ramos-Leví and Marazuela, Endocrine, 2018; Tewari et al., 2026).
- Common but milder reactions:injection-site reactions, headache, diarrhea, and flushing were common with CJC-1295 in its early trial (Tewari et al., 2026; Mendias and Awan, 2026). Tell your doctor about them, especially if they do not go away.
- Anything new and unexplained,such as a new lump, weight loss you cannot explain, or a change in a mole, should be checked by a doctor rather than watched, given the possible concerns about growth signals.
Keep a simple log with the product name, supplier, lot number, date, injection site, and any symptoms. Bring the vial or label to your appointments. If you have a side effect, ask your doctor to report it to the FDA through its MedWatch program, or report it yourself. Compounding pharmacies are not required to report side effects (Samantaroy et al., 2026), so voluntary reports are one of the few ways safety problems come to light.
How long to use a peptide
There is no answer backed by evidence. Animal studies of BPC-157 used anything from a single dose to daily doses for up to 90 days, depending on the type of injury studied (McGuire et al., 2025). Animal schedules do not carry over directly to people, and no human trial has set a treatment length. For none of these peptides do we have human safety data beyond about 2 years, and even that comes only from small groups of older adults (Tewari et al., 2026).
A practical approach is to set a trial period with a planned check-in. Compare your results with the goal you set at the start, and stop if you have not improved in a meaningful way. Using a product with no end date, or repeating cycles, adds up your exposure to something whose long-term effects are unknown. If you use a growth hormone booster, repeat your baseline labs during the course, not just at the end.
Questions to ask whoever prescribes, sells, or administers a peptide
- What exactly is this product, and where was it made? Is it from a state-licensed pharmacy, or sold as "research use only"?
- Has this specific batch (lot) been tested by an independent lab to confirm what it is, how pure it is, that it is sterile, and that it is free of bacterial toxins (endotoxin)? Can I see the results?
- What evidence in people, not just animals, shows this peptide helps my specific condition?
- What result should I expect, by when, and how will we measure it? At what point do we stop?
- Which side effects should I watch for, and who do I call after hours if I have one?
- Which lab tests should I have before and during treatment?
- How does this interact with my other medications, supplements, and health conditions, including diabetes, heart disease, or a history of cancer?
- How does this fit with my rehab or an upcoming surgery? Should my surgeon and anesthesia team know?
- Am I drug tested, and could this cause a positive result?
- What does it cost? Does the practice sell the product directly, and if so, where does it come from?
Be wary of any source that promises a cure, offers no follow-up, cannot tell you where the product was made, or tells you not to mention it to your surgeon or primary care doctor.
This post is for education only. It is not medical advice, it does not recommend any peptide, and it does not replace an in-person visit with a doctor. We include the safety guidance above because many people already use these products, and preventing avoidable harm matters no matter what they choose. This post does not give doses or treatment plans. We do not promise that any peptide discussed here will heal, cure, or replace other treatment.





